Viewing data from:

SUCRALFATE

ANDA

SUCRALFATE | A216474 | STRIDES PHARMA GLOBAL PTE LTD

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: CARAFATE(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 1 NDC

Highest NADAC/Unit

$0.1174

per ml

Lowest NADAC/Unit

$0.1174

per ml

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
64380014901SUCRALFATE 1 GM/10 ML SUSP	$0.1174	ML	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 1 NDC (1 FSS)

Lowest Price

$58.71

Highest Price

$58.71

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
72162-2479-02SUCRALFATE 500MG/5ML SUSP,ORAL	$58.71	FSS	Bryant Ranch PrePack DBA Bryant Ranch PrePack	04/30/2026

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain11 active DMFs10 inactive

9 active API suppliers hold Drug Master Files for this ingredient.

FUJI CHEMICAL INDUSTRIES CO LTDSUCRALFATE

DMF 35421979

ACE JAPAN CO LTDSUCRALFATE (SUCROSE SULFATE ALUMINUM SALT)

DMF 61081985

ARCHIMICA SPASUCRALFATE

DMF 165892003

ZHEJIANG HAISEN PHARMACEUTICAL CO LTDSUCRALFATE NON STERILE BULK DRUG SUBSTANCE

DMF 300562016

ALIVUS LIFE SCIENCES LTDSUCRALFATE USP

DMF 334792019

ALIVUS LIFE SCIENCES LTDSUCRALFATE USP (PROCESS-II)

DMF 375022022

MSN LIFE SCIENCES PRIVATE LTDSUCRALFATE USP

DMF 381522023

SNJ LABS PVT LTDSUCRALFATE USP

DMF 388672023

THINQ PHARMA-CRO LTDSUCRALFATE USP

DMF 401452024

GULBRANDSEN TECHNOLOGIES (INDIA) PRIVATE LTDSUCRALFATE USP

DMF 410322024

SNJ LABS PVT LTDSUCRALFATE (SUF) USP

DMF 426412025

ORION CORP LTDInactiveSUCRALFATE

DMF 54541984

ORGAMOL SAInactiveSUCRALFATE

DMF 58251985

NIPPON KAYAKU CO LTDInactiveSUCRALFATE

DMF 60481985

SHANGHAI NO 6 PHARMACEUTICAL FACTORYInactiveSUCRALFATE

DMF 60571985

UNICHEM LABORATORIES LTDInactiveSUCRALFATE

DMF 63311985

ISTITUTO CHEMICOTHERAPICO ITALIANOInactiveSUCRALFATE

DMF 71861987

NANJING PHARMACEUTICAL FACTORY CO LTDInactiveSUCRALFATE

DMF 72821988

NORTHEAST PHARMACEUTICAL GROUP CO LTDInactiveSUCRALFATE

DMF 75521988

SMITH KLINE & FRENCH LABS DIV SMITHKLINE BECKMAN CORPInactiveSUCRALFATE

DMF 78381988

BK GIULINI GMBHInactiveSUCRALFATE POWDER

DMF 118761996

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 1GM/10ML

0 patents0 exclusivities▴

SUSPENSION;ORAL | Approved: May 21, 2024

No patent or exclusivity listings for this strength.